Merkel cell carcinoma patients with solid organ transplant or hematologic malignancy: Demographics, survival, and prognosticators

J Am Acad Dermatol. 2022 Jun;86(6):1385-1387. doi: 10.1016/j.jaad.2021.05.042. Epub 2021 May 31.

Authors

Nolan J Maloney¹, Jason J Yang¹, Lisa C Zaba²

Affiliations

¹ Veterans Affairs Palo Alto Healthcare System, Palo Alto, California; Department of Dermatology, Stanford University School of Medicine, Palo Alto, California.
² Veterans Affairs Palo Alto Healthcare System, Palo Alto, California; Department of Dermatology, Stanford University School of Medicine, Palo Alto, California. Electronic address: [email protected].

PMID: 34082038
DOI: 10.1016/j.jaad.2021.05.042

No abstract available

Publication types

Research Support, N.I.H., Extramural

MeSH terms

Carcinoma, Merkel Cell* / diagnosis
Carcinoma, Merkel Cell* / epidemiology
Demography
Hematologic Neoplasms* / diagnosis
Hematologic Neoplasms* / epidemiology
Humans
Organ Transplantation* / adverse effects
Skin Neoplasms* / pathology